Algaia Receives €4 Million Equity Increase for New Seaweed Extract Facility, Expanded Innovation Center
The equity increase will allow the alginates firm to install a new specialty seaweed extract production unity in its Lannilis, France, manufacturing facility and to ramp up its production of specialty functional algae ingredients above and beyond the firm’s traditional seaweed ingredients.
Photo © iStockphoto.com/BryanToro
Alginates producer Algaia S.A. (Paris) has received a €4 million equity boost from its main shareholder, Israel-based Maabarot Products Ltd., to further develop its algae production capabilities. The equity increase will allow Algaia to install a new specialty seaweed extract production unit in its Lannilis, France, manufacturing facility and to ramp up its production of specialty functional algae ingredients above and beyond the firm’s traditional seaweed ingredients. It will also help to expand its innovation center in Normandy.
In 2017 and in 2018, Algaia invested €5 million in its Lannilis facilities to develop new marine ingredients, improve processing, and increase capacity. The company said that with the new equity investment, it will install a specialty algae extract production line based on innovative technology that it has developed over the past three years. The new production unit will also expand Algaia’s existing alginates portfolio beyond traditional seaweed extracts to include functional liquid products for the agricultural technology space.
“We are pleased with the rapid growth of Algaia,” said Eyal Shalmon, chairman, Maabarot Products Ltd., in a press release. “We continue to strive to position Algaia as a leader in the algae extracts market.”
Algaia also said that the equity increase will help increase its global presence in the alginates market. Said Fabrice Bohin, CEO, Algaia, in the press statement: “We are expanding both our portfolio and our geographical presence. Innovative products and technologies are currently being developed for launch in the coming months. We also are strengthening our positions in the Americas where, as in Europe, we identified a growing interest in marine-derived ingredients.”
He continued: “We are pleased to see our shareholders committed to Algaia’s growth plans and we look forward to continuing our growth both organically and via acquisition of specialty marine-based companies.”
Also read:
AIDP and Algaia Launch Seaweed Extract for Clean-Label Dessert Applications
Marine Nutraceutical Ingredients Dive Into Beverages
Algae Is a Versatile Ingredient for Food, Beverages, and Supplements
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.
